XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Statements of Changes in Stockholders' Equity (Deficiency) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 61 $ 24,389,307 $ (35,519,819) $ (11,130,451)
Balance, shares at Dec. 31, 2017 6,133,678      
Stock-based compensation: Amortization of stock options 137,376 137,376
Net loss (4,747,487) (4,747,487)
Balance at Mar. 31, 2018 $ 61 24,526,683 (40,267,306) (15,740,562)
Balance, shares at Mar. 31, 2018 6,133,678      
Balance at Dec. 31, 2018 $ 117 50,598,854 (48,562,528) 2,036,443
Balance, shares at Dec. 31, 2018 11,722,647      
Stock-based compensation: Amortization of stock options 82,720 82,720
Common stock issued private placement offering [1] $ 24 2,317,252 2,317,276
Common stock issued private placement offering, shares [1] 2,347,997      
Stock-based compensation: Common stock issued to consultants    
Stock-based compensation: Common stock issued to consultants, shares 85,000      
Stock-based compensation: Warrants granted to consultants 2,334 2,334
Net loss (1,573,726) (1,573,726)
Balance at Mar. 31, 2019 $ 141 $ 53,001,160 $ (50,136,254) $ 2,865,047
Balance, shares at Mar. 31, 2019 14,155,644      
[1] net of offering costs of $386,724.